Full Text View
Tabular View
No Study Results Posted
Related Studies
Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas (CatuNeo)
This study is currently recruiting participants.
Verified August 2012 by AIO-Studien-gGmbH
Study NCT01504256   Information provided by AIO-Studien-gGmbH

First Received on January 3, 2012.   Last Updated on August 16, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Adenocarcinoma
Adenocarcinoma, Mucinous
Carcinoma
Stomach Neoplasms
More general conditions related to this trial
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Cystic, Mucinous, and Serous
Neoplasms, Glandular and Epithelial
Stomach Diseases
Additional drug interventions recognized in this trial
Antibodies, Bispecific
Docetaxel
Fluorouracil
Leucovorin
Levoleucovorin
Oxaliplatin
More general drug interventions related to this trial
Antidotes
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Growth Substances
Immunologic Factors
Immunosuppressive Agents
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Vitamin B Complex
Vitamins
Sponsors listed in this trial
AIO-Studien-gGmbH
Fresenius Biotech GmbH


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services